Metabolomics as a Tool for Discovery – PLOS | ONE article
Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children
The diagnosis of autism spectrum disorder (ASD) at the earliest age possible is important for initiating optimally effective intervention. In the United States the average age of diagnosis is 4 years. Identifying metabolic biomarker signatures of ASD from blood samples offers an opportunity for development of diagnostic tests for detection of ASD at an early age.
Read the Full Publication
Posters & Publications
- The Children’s Autism Metabolome Project (CAMP) was the largest study to date to evaluate the metabolism of childre… https://t.co/QPXCK0ICpV2 days ago
- Which environment is better for the delivery of autism intervention services? Home or an autism research center? Th… https://t.co/n057kPdpU22 days ago
- Though about half of people with autism also have an intellectual disability, a recent meta-analysis of 100s of aut… https://t.co/dDGzFFRDSD2 days ago